APA (7th ed.) Citation

S, T., NJ, V., SG, H., W, S., MJ, G., BF, B., . . . JL, W. (2015). Antisense therapy targeting apolipoprotein(a): A randomised, double-blind, placebo-controlled phase 1 study. Lancet (London, England), 386(10002), 1472. https://doi.org/10.1016/S0140-6736(15)61252-1

Chicago Style (17th ed.) Citation

S, Tsimikas, et al. "Antisense Therapy Targeting Apolipoprotein(a): A Randomised, Double-blind, Placebo-controlled Phase 1 Study." Lancet (London, England) 386, no. 10002 (2015): 1472. https://doi.org/10.1016/S0140-6736(15)61252-1.

MLA (9th ed.) Citation

S, Tsimikas, et al. "Antisense Therapy Targeting Apolipoprotein(a): A Randomised, Double-blind, Placebo-controlled Phase 1 Study." Lancet (London, England), vol. 386, no. 10002, 2015, p. 1472, https://doi.org/10.1016/S0140-6736(15)61252-1.